The DTx East 2018 summit brought together all the relevant companies and the leading thinkers in the field, for 2 days of topical discussion.
This review paper, written by an independent author, distills the essence of these conversations.
Evidence generation, FDA clearance, and reimbursement are some of the key topics featured in this report.
Plus discover perspectives on the current and future direction of this sector from industry leaders and key stakeholders including:
- Eddie Martucci, CEO, Akili Interactive Labs
- Ruchita Sinha, Senior Director of Investments, Sanofi Ventures
- Bakul Patel, Associate Director for Digital Health, FDA
For anyone working in the digital therapeutics field, this DTx East review is a must-read.